Angiogenesis Inhibitor TNP-470 Can Suppress Hepatocellular Carcinoma Growth Without Retarding Liver Regeneration After Partial Hepatectomy | Zendy

Shigeki KINOSHITA | Zendy; Ryuji Hirai | Zendy; Toshihisa Yamano | Zendy; Ichiro Yuasa | Zendy; Kazunori Tsukuda | Zendy; Nobuyoshi Shimizu | Zendy

Open Access

Angiogenesis Inhibitor TNP-470 Can Suppress Hepatocellular Carcinoma Growth Without Retarding Liver Regeneration After Partial Hepatectomy

Author(s) -

Shigeki KINOSHITA,

Ryuji Hirai,

Toshihisa Yamano,

Ichiro Yuasa,

Kazunori Tsukuda,

Nobuyoshi Shimizu

Publication year - 2004

Publication title -

surgery today

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.655

H-Index - 63

eISSN - 1436-2813

pISSN - 0941-1291

DOI - 10.1007/s00595-003-2645-9

Subject(s) - liver regeneration , hepatocellular carcinoma , medicine , hepatectomy , angiogenesis , transaminase , bilirubin , regeneration (biology) , microvessel , liver cancer , gastroenterology , endocrinology , pathology , surgery , chemistry , biochemistry , enzyme , biology , microbiology and biotechnology , resection

We investigated the suppressive effect of the angiogenesis inhibitor TNP-470 on accelerated hepatocellular carcinoma (HCC) growth in the regenerating liver.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research